Spero Therapeutics, Inc.
USD2.26
+0.00 (+0.00%)
CEO
Esther Rajavelu
IPO Date
2017-11-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.25
Prev. Close
$2.26
Day Low
$2.25
Day High
$2.33
52W Low
$1.80
52W High
$3.22
Market Cap
$0.13B
Volume
0.52M
| 20,000 |
| $2.15 |
| 25 Jun 2026 | Tregoning Kathleen | director | A-Award | Acquired | 10,000 | $0.00 |
| 25 Jun 2026 | Tregoning Kathleen | director | A-Award | Acquired | 20,000 | $2.15 |
| 25 Jun 2026 | Smith Cynthia | director | A-Award | Acquired | 10,000 | $0.00 |
| 25 Jun 2026 | Smith Cynthia | director | A-Award | Acquired | 20,000 | $2.15 |
| 25 Jun 2026 | VINK PATRICK V.J.J. | director | A-Award | Acquired | 10,000 | $0.00 |
| 25 Jun 2026 | VINK PATRICK V.J.J. | director | A-Award | Acquired | 20,000 | $2.15 |
| 25 Jun 2026 | THOMAS FRANK E | director | A-Award | Acquired | 10,000 | $0.00 |
| 25 Jun 2026 | THOMAS FRANK E | director | A-Award | Acquired | 20,000 | $2.15 |